Loading Filters
Showing 1–4 of 4 results
-
Research |
Variant alleles in factor V, prothrombin, plasminogen activator inhibitor-1, methylenetetrahydrofolate reductase and risk of thromboembolism in metastatic colorectal cancer patients treated with first-line chemotherapy plus bevacizumab
- F S Falvella
- , C Cremolini
- , R Miceli
- , F Nichetti
- , S Cheli
- , C Antoniotti
- , G Infante
- , A Martinetti
- , F Marmorino
- , E Sottotetti
- , R Berenato
- , M Caporale
- , A Colombo
- , F de Braud
- , M Di Bartolomeo
- , E Clementi
- , F Loupakis
- & F Pietrantonio
The Pharmacogenomics Journal 17 , 331–336 -
Research |
Prospective study of EGFR intron 1 (CA)n repeats variants as predictors of benefit from cetuximab and irinotecan in chemo-refractory metastatic colorectal cancer (mCRC) patients
- F Loupakis
- , C Antoniotti
- , C Cremolini
- , W Zhang
- , D Yang
- , T Wakatsuki
- , P Bohanes
- , M Schirripa
- , L Salvatore
- , G Masi
- , V Ricci
- , F Graziano
- , A Ruzzo
- , L Benhaim
- , F Marmorino
- , Y Ning
- , R El-Khoueiry
- , A Falcone
- & H-J Lenz
The Pharmacogenomics Journal 14 , 322–327 -
| Open
-
| Open
